PT Diagnos Laboratorium Utama Tbk

Jakarta Stock Exchange DGNS.JK

PT Diagnos Laboratorium Utama Tbk Operating Income Margin for the year ending December 31, 2023: -10.40%

PT Diagnos Laboratorium Utama Tbk Operating Income Margin is -10.40% for the year ending December 31, 2023, a -213.59% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

PT Diagnos Laboratorium Utama Tbk Operating Income Margin for the year ending December 31, 2022 was 9.15%, a -65.96% change year over year.
PT Diagnos Laboratorium Utama Tbk Operating Income Margin for the year ending December 31, 2021 was 26.90%, a -26.50% change year over year.
PT Diagnos Laboratorium Utama Tbk Operating Income Margin for the year ending December 31, 2020 was 36.59%, a 42.29% change year over year.
PT Diagnos Laboratorium Utama Tbk Operating Income Margin for the year ending December 31, 2019 was 25.72%, a -20.29% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Jakarta Stock Exchange: DGNS.JK

PT Diagnos Laboratorium Utama Tbk

CEO	Engineer Mesha Rizal Sini
IPO Date	Jan. 15, 2021
Location	Indonesia
Headquarters	Gedung Graha Anam Lantai 2
Employees	91
Sector	Health Care
Industries Hospitals & Clinics Biotechnology

Description

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing, preimplantation genetic testing for aneuploidy services, and preimplantation genetic testing for monogenic diseases services. It also offers homecare health services for health checks that can be done at home; corporate health services; and covid-19 check-up services, as well as health care activities managed by the government and the private sector, such as pharmacy warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other health care services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Key trends

Past 5 years